IP Library Granted Patent US 7,410,458
Granted Patent B2
US 7,410,458 · App. 10/712,820 · Granted Aug 12, 2008

Brachytherapy implant seeds

Assignee: IsoRay Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,410,458
App. No.
10/712,820
Granted
Aug 12, 2008
Kind
B2
Abstract

This invention includes methods of fabricating brachytherapy implant seeds, methods of fabricating brachytherapy implant seed cores, and brachytherapy implant seeds independent of method of fabrication. In one implementation, a brachytherapy implant seed includes a sealed inorganic metallic cylinder having a radioactive core received therein. The radioactive core includes an inorganic amorphous silicate glass tube having an exterior surface extending axially along the tube. An inorganic crystalline ceramic coating is received on at least a portion of the inorganic amorphous glass tube exterior surface. The coating includes a therapeutic dose of radioactive material. A radiographic marker is received within the sealed inorganic metallic cylinder. Other aspects and implementations are contemplated.

Claims (35)

1. A brachytherapy implant seed comprising:

a sealed inorganic metallic cylinder having a radioactive core received therein, the radioactive core comprising:

an inorganic amorphous silicate glass tube having an exterior surface extending axially along the tube; and

an inorganic crystalline ceramic coating received on at least a portion of the inorganic amorphous glass tube exterior surface, said coating comprising a therapeutic dose of radioactive material; and a radiographic marker received within the sealed inorganic metallic cylinder.

2. The brachytherapy implant seed of claim 1 wherein the glass comprises borosilicate.

3. The brachytherapy implant seed of claim 1 wherein the glass comprises phosphosilicate.

4. The brachytherapy implant seed of claim 1 wherein the inorganic crystalline ceramic comprises a metal silicate.

5. The brachytherapy implant seed of claim 4 wherein the inorganic crystalline ceramic comprises an aluminosilicate.

6. The brachytherapy implant seed of claim 1 wherein the therapeutic dose of radioactive material coats all of the tube exterior surface.

7. The brachytherapy implant seed of claim 1 wherein the therapeutic dose of radioactive material coats less than all of the tube exterior surface.

8. The brachytherapy implant seed of claim 7 wherein the therapeutic dose of radioactive material does not coat from 1.0 mm to 4.0 mm of a longitudinal central portion of the tube.

9. The brachytherapy implant seed of claim 1 wherein the inorganic crystalline ceramic coating has a thickness of from 0.1 mm. to 0.4 mm.

10. The brachytherapy implant seed of claim 1 wherein the inorganic crystalline ceramic coating has a thickness which is substantially the same as that of the inorganic amorphous silicate glass tube.

11. The brachytherapy implant seed of claim 1 wherein the inorganic crystalline ceramic coating has a thickness which is greater than that of the inorganic amorphous silicate glass tube.

12. The brachytherapy implant seed of claim 1 wherein the inorganic crystalline ceramic coating has a thickness which is less than that of the inorganic amorphous silicate glass tube.

13. The brachytherapy implant seed of claim 1 wherein the inorganic amorphous silicate glass tube comprises longitudinally opposing ends which are sealed by inorganic amorphous silicate glass.

14. The brachytherapy implant seed of claim 1 wherein the radiographic marker is received within the inorganic amorphous silicate glass tube.

15. The brachytherapy implant seed of claim 1 comprising a pair of balls received within longitudinal ends of the sealed inorganic metallic cylinder.

16. The brachytherapy implant seed of claim 15 wherein the balls comprise radiographic marker material.

17. The brachytherapy implant seed of claim 15 wherein the balls comprise a therapeutic dose of radioactive material.

18. The brachytherapy implant seed of claim 15 wherein the balls comprise an inorganic crystalline ceramic coated with a therapeutic dose of radioactive material.

19. A brachytherapy implant seed comprising:

a sealed inorganic metallic cylinder;

a tubular core received within the sealed inorganic metallic cylinder and having an inner layer and a outer layer, the inner layer comprising an inorganic amorphous silicate glass tube having an exterior surface extending along a length of the glass tube, and the outer layer comprising an inorganic crystalline ceramic received on at least a portion of the exterior surface of the inner layer;

a therapeutic dose of radioactive material applied to at least a portion of the outer layer of the tubular core; and

a radiographic marker received within the sealed inorganic metallic cylinder.

20. The brachytherapy implant seed of claim 19 wherein the outer layer of the tubular core is received on an entire length of the exterior surface of the inner layer of the tubular core.

21. The brachytherapy implant seed of claim 19 wherein the outer layer of the tubular core is received on less than the entire length of the exterior surface of the first layer of the tubular core.

22. The brachytherapy implant seed of claim 19 wherein the therapeutic dose of radioactive material is applied to an entire outer surface of the outer layer of the tubular core.

23. The brachytherapy implant seed of claim 19 wherein the therapeutic dose of radioactive material is applied to less than the entire outer surface of the outer layer of the tubular core.

24. The brachytherapy implant seed of claim 23 wherein the therapeutic dose of radioactive material is not applied to a 1.0 mm to 4.0 mm longitudinal central portion of the outer surface of the outer layer of the tubular core.

25. The brachytherapy implant seed of claim 19 wherein the outer layer of the tubular core has a thickness of from 0.1 mm. to 0.4 mm.

26. The brachytherapy implant seed of claim 19 wherein the outer layer of the tubular core has a thickness which is substantially the same as that of the inner layer of the tubular core.

27. The brachytherapy implant seed of claim 19 wherein the outer layer of the tubular core has a thickness which is greater than that of the inner layer of the tubular core.

28. The brachytherapy implant seed of claim 19 wherein the outer layer of the tubular core has a thickness which is less than that of the inner layer of the tubular core.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2024
From: ISORAY MEDICAL, INC.
To: GT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 068158/0875 →
MERGER Recorded Mar 29, 2006
From: ISORAY, INC.
To: ISORAY MEDICAL, INC.
Reel/Frame 017405/0196 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2003
From: BRAY, LANE A.; MADSEN, JAMES L.; BROWN, GARRETT N.; LAWRENCE, DONALD C.; SWANBERG, DAVID L.; DRAPER, JAY; BALES, MATTHEW J.
To: ISORAY, INC.
Reel/Frame 014704/0667 →
Continuity (1)
Related Publication 20050101826A1 · May 12, 2005